Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
ROSSARI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Rossari Biotech's promoter Sunil Srinivasan Chari is gifting 88,00,000 equity shares (15.89% of total share capital) to members of his family as an off-market inter-se transfer without any consideration. The shares are being split between his son Yash Sunil Chari (23 lakh shares, 4.15%), wife Jyotishna Sunil Chari (15 lakh shares, 2.71%), and the Chari Family Trust (50 lakh shares, 9.03%). The transaction is scheduled to happen on or after August 28, 2025. After the transfer, Sunil Chari's individual holding will drop from 29.06% to 13.17%, while the Chari Family Trust will hold 9.23%. The total promoter and promoter group holding remains unchanged before and after the transaction, and the transfer is exempt from open offer requirements under SEBI SAST Regulations.
This is purely a private family estate restructuring move with no shares hitting the market and no change in aggregate promoter ownership, so it is unlikely to have any direct impact on the stock price. Shareholders should view this as neutral; the company has confirmed no change in overall promoter control or concentration.